- CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS
-
The invention relates to compounds for increasing GPR40 recetpor activity and application thereof. These compounds include of a compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, isomers thereof, or produgs of the compou
- -
-
Page/Page column 36
(2015/03/13)
-
- INDANYLOXYPHENYLCYCLOPROPANECARBOXYLIC ACIDS
-
The present invention relates to compounds of general formula I, wherein the groups R1, R2, R3, m and n are defined as in claim 1, which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.
- -
-
Paragraph 0435
(2014/01/07)
-
- FUSED CYCLIC COMPOUNDS
-
The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof. The compound or a salt thereof or a prodrug thereof has a GPR40 receptor function modulating action and is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
- -
-
Page/Page column 101
(2008/06/13)
-